InMed Pharmaceuticals Inc. (INM) — Gross Profit

Annual figures by fiscal year, from SEC filings.

2022: $543.5K2023: $1.40M2024: $1.10M2025: $1.71M$1.71M
2022Gross Profit (USD)2025
Fiscal YearGross ProfitChange YoY
2025$1.71M+55.0%
2024$1.10M-21.5%
2023$1.40M+158.1%
2022$543.5K